Free for academic non-profit institutions. Other users need a Commercial license
This gene encodes a member of the Abelson family of nonreceptor tyrosine protein kinases. The protein is highly similar to the c-abl oncogene 1 protein, including the tyrosine kinase, SH2 and SH3 domains, and it plays a role in cytoskeletal rearrangements through its C-terminal F-actin- and microtubule-binding sequences. This gene is expressed in both normal and tumor cells, and is involved in translocation with the ets variant 6 gene in leukemia. Multiple alternatively spliced transcript variants encoding different protein isoforms have been found for this gene. [provided by RefSeq, Nov 2009]
ABL2 (ABL Proto-Oncogene 2, Non-Receptor Tyrosine Kinase) is a Protein Coding gene. Diseases associated with ABL2 include Leukemia and Leukemia, Chronic Myeloid. Among its related pathways are Guidance Cues and Growth Cone Motility and Signaling by Slit. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring phosphorus-containing groups and protein tyrosine kinase activity. An important paralog of this gene is ABL1.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000166 | nucleotide binding | IEA | -- |
GO:0000287 | magnesium ion binding | IDA | 15886098 |
GO:0001784 | phosphotyrosine residue binding | IPI | 20624904 |
GO:0003785 | actin monomer binding | TAS | 20841568 |
GO:0004672 | protein kinase activity | TAS | 2198571 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005623 | cell | IEA | -- |
GO:0005737 | cytoplasm | IEA | -- |
GO:0005829 | cytosol | TAS | -- |
GO:0005856 | cytoskeleton | IEA | -- |
GO:0015629 | actin cytoskeleton | TAS | 20841568 |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Developmental Biology |
.51
|
|
2 | Signaling by Robo receptor | ||
3 | ErbB signaling pathway | ||
4 | Ras signaling pathway | ||
5 | Allograft rejection |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0006464 | cellular protein modification process | TAS | 2198571 |
GO:0006468 | protein phosphorylation | IEA | -- |
GO:0007155 | cell adhesion | IEA | -- |
GO:0007165 | signal transduction | TAS | 2198571 |
GO:0007204 | positive regulation of cytosolic calcium ion concentration | IMP | 24367707 |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Dasatinib | Approved, Investigational | Pharma | Target, multitarget, Inhibition, inhibitor | Kinase Inhibitors, SRC/BCR-ABL tyrosine kinase inhibitors | 324 | |
fostamatinib | Approved, Investigational | Pharma | Target, inhibitor | Kinase Inhibitors | 0 | |
Magnesium | Approved, Experimental, Investigational | Pharma | 0 | |||
Manganese | Approved | Nutra | 56 | |||
K-00546 | Experimental | Pharma | Target | 0 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
ADP |
|
Agonist, Full agonist, Partial agonist, Gating inhibitor, Antagonist | 58-64-0 |
|
Compound | Action | Cas Number |
---|---|---|
Bafetinib (INNO-406) | Bcr-Abl/Lyn tyrosine kinase inhibitor | 887650-05-7 |
Bosutinib (SKI-606) | Potent Abl/Src kinases | 380843-75-4 |
DCC-2036 (Rebastinib) | Bcr-Abl inhibitor | 1020172-07-9 |
GNF 2 | Bcr-Abl inhibitor | 778270-11-4 |
GNF 5 | Bcr-Abl inhibitor | 778277-15-9 |
GZD824 | Bcr-Abl inhibitor,novel orally bioavailable | 1421783-64-3 |
Imatinib Mesylate (STI571) | Abl/c-kit/PDGFR inhibitor | 220127-57-1 |
KW 2449 | Multikinase inhibitor | 1000669-72-6 |
Nilotinib monohydrochloride monohydrate | 923288-90-8 | |
Nilotinib(AMN-107) | Bcr-Abl kinase inhibitor,selective | 641571-10-0 |
PD173955 | Dual Src/Abl kinase inhibitor, ATP-competitive, | 260415-63-2 |
PP121 | Dual inhibitor of tyrosine and phosphoinositide kinases | 1092788-83-4 |
This gene was present in the common ancestor of animals.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | ABL2 30 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | ABL2 30 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | ABL2 30 31 |
|
OneToOne | |
Mouse (Mus musculus) |
Mammalia | Abl2 30 17 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Abl2 30 |
|
||
Oppossum (Monodelphis domestica) |
Mammalia | ABL2 31 |
|
OneToOne | |
Platypus (Ornithorhynchus anatinus) |
Mammalia | ABL2 31 |
|
OneToOne | |
Chicken (Gallus gallus) |
Aves | ABL2 30 31 |
|
OneToOne | |
Lizard (Anolis carolinensis) |
Reptilia | ABL2 31 |
|
OneToOne | |
Tropical Clawed Frog (Silurana tropicalis) |
Amphibia | abl2 30 |
|
||
Zebrafish (Danio rerio) |
Actinopterygii | abl2 30 31 |
|
OneToOne | |
Fruit Fly (Drosophila melanogaster) |
Insecta | Abl 31 32 |
|
OneToMany | |
Worm (Caenorhabditis elegans) |
Secernentea | T21G5.1 32 |
|
|
|
kin-9 32 |
|
|
|||
W04G5.10 32 |
|
|
|||
spe-8 32 |
|
|
|||
F57B9.8 32 |
|
|
|||
Y38H6C.20 32 |
|
|
|||
F22B3.8 32 |
|
|
|||
abl-1 31 32 |
|
OneToMany | |||
kin-26 32 |
|
|
|||
C25A8.5 32 |
|
|
|||
F23C8.7 32 |
|
|
|||
T25B9.4 32 |
|
|
|||
T25B9.5 32 |
|
|
|||
Y69E1A.3 32 |
|
|
|||
W01B6.5 32 |
|
|
|||
K09B11.5 32 |
|
|
|||
R11E3.1 32 |
|
|
|||
ZK593.9 32 |
|
|
|||
Y52D5A.2 32 |
|
|
|||
Sea Squirt (Ciona savignyi) |
Ascidiacea | -- 31 |
|
OneToMany |
SNP ID | Clinical significance and condition | Chr 01 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
715839 | Likely Benign: not provided | 179,108,917(-) | T/A | MISSENSE_VARIANT,INTRON_VARIANT | |
758688 | Likely Benign: not provided | 179,117,342(-) | A/C | SYNONYMOUS_VARIANT | |
770497 | Benign: not provided | 179,108,478(-) | T/C | MISSENSE_VARIANT | |
rs1553236156 | Uncertain Significance: Inborn genetic diseases | 179,229,355(-) | G/A | NONSENSE | |
rs386352273 | Uncertain Significance: not provided | 179,109,182(-) | T/C | SYNONYMOUS_VARIANT,INTRON_VARIANT |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
dgv469n100 | CNV | gain | 25217958 |
dgv470n100 | CNV | gain | 25217958 |
esv3575327 | CNV | gain | 25503493 |
esv3578288 | CNV | loss | 25503493 |
esv3588047 | CNV | loss | 21293372 |
nsv1001191 | CNV | loss | 25217958 |
nsv1002511 | CNV | gain | 25217958 |
nsv1005278 | CNV | gain | 25217958 |
nsv1009493 | CNV | gain | 25217958 |
nsv1122423 | CNV | deletion | 24896259 |
nsv1137825 | CNV | deletion | 24896259 |
nsv946521 | CNV | duplication | 23825009 |
nsv946522 | CNV | duplication | 23825009 |
Disorder | Aliases | PubMed IDs |
---|---|---|
leukemia |
|
|
leukemia, chronic myeloid |
|
|